NCT04953871View on ClinicalTrials.gov

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

January 31, 2018

Conditions
SpondyloarthritisEnthesitisAnti-Tumor Necrosis Factor Drugs
Interventions
DRUG

TNF Inhibitor

TNF inhibitors are widely used in patients with spondyloarthritis

All Listed Sponsors
lead

Gunay ER

OTHER

NCT04953871 - Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis | Biotech Hunter | Biotech Hunter